cepharanthine has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; He, X; Li, S; Lin, S; Xu, M; Xu, X; Yuan, G; Zhang, Y | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Li, X; Liu, W; Wang, H; Wang, T; Wang, X; Wang, Y; Zhang, Y | 1 |
| Byun, S; Lee, E; Lee, KW | 1 |
| Ai, N; Dang, Y; Ge, W; Head, SA; Kwon, HJ; Li, RJ; Liu, JO; Liu, Y; Lyu, J; Shim, JS; Wu, C; Yang, C; Yang, EJ; Zhang, B | 1 |
| Furusawa, S; Wu, J | 1 |
| Morita, K; Ohta, T | 1 |
4 review(s) available for cepharanthine and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
A mechanistic updated overview on Cepharanthine as potential anticancer agent.
Topics: Antineoplastic Agents; Benzylisoquinolines; Cell Proliferation; Humans; Neoplasms | 2023 |
Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.
Topics: Adaptive Immunity; Animals; Autoimmune Diseases; Autophagy; Benzylisoquinolines; Cholecalciferol; Humans; Immune System Diseases; Immunity, Innate; Indoles; Infections; Isoquinolines; Lysosomes; Maprotiline; Metformin; Neoplasms; Phenols; Pyrroles; Resveratrol; Sirolimus; Spermidine; Stilbenes; Tetrahydroisoquinolines; Trehalose | 2017 |
The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Disease Models, Animal; Humans; Molecular Structure; Neoplasms; Shock, Septic; Tumor Cells, Cultured | 2007 |
1 trial(s) available for cepharanthine and Neoplasms
| Article | Year |
|---|---|
[Effect of cepharanthin on radiotherapy induced leukopenia].
Topics: Adrenochrome; Alkaloids; Benzylisoquinolines; Cysteine; Female; Humans; Leukopenia; Neoplasms; Radiation-Protective Agents; Radiotherapy; Randomized Controlled Trials as Topic | 1990 |
2 other study(ies) available for cepharanthine and Neoplasms
| Article | Year |
|---|---|
Formation, recognition and bioactivities of a novel G-quadruplex in the STAT3 gene.
Topics: 3' Flanking Region; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Cells, Cultured; Down-Regulation; Drug Design; G-Quadruplexes; Gene Expression; Gene Expression Regulation; Humans; Ligands; Luciferases; Molecular Targeted Therapy; Myocytes, Cardiac; Neoplasms; STAT3 Transcription Factor | 2011 |
Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth.
Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Cell Growth Processes; Cholesterol; Cisplatin; Drug Synergism; Human Umbilical Vein Endothelial Cells; Humans; Lysosomes; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; Neovascularization, Pathologic; Tumor Microenvironment; Xenograft Model Antitumor Assays; Zebrafish | 2017 |